← back to search

Kwun M. Fong

The University of Queensland · AU
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, and RNA modifications and cancer.
h-index
100
citations
75,576
works
615
NIH funding
primary concept
Medicine
email

Recent publications

Comparative Liquid Biopsy Testing for KRAS Mutations From Plasma Cell-Free DNA (cfDNA) and Extracellular Vesicles in Lung Adenocarcinoma.
2026cited by 0position: contributordoi
Rationale for the Nodule Management Protocol of the Australian National Lung Cancer Screening Program.
2026cited by 0position: contributordoi
Why PD-L1 expression varies between studies of lung cancer: results from a Bayesian meta-analysis
Scientific Reports 2025cited by 12position: middledoi
Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement
American Journal of Respiratory and Critical Care Medicine 2025cited by 12position: middledoi
Potential utility of miRNAs derived from pleural fluid extracellular vesicles to differentiate between benign and malignant pleural effusions.
2025cited by 9position: contributordoi
Safety and Sample Adequacy for Comprehensive Biomarker Testing of Bronchoscopic Biopsies: An American Association of Bronchology and Interventional Pulmonology and International Association for the Study of Lung Cancer Clinical Practice Guideline
Journal of Thoracic Oncology 2025cited by 9position: middledoi
Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement.
2025cited by 7position: contributordoi
Lessons Learned From International Lung Cancer Screening Trials; People at Risk Deserve Screening for Early Detection.
2025cited by 3position: contributordoi
World Lung Day 2025-Healthy Lungs, Healthy Life.
2025cited by 1position: contributordoi
Lung Cancer Screening Participation Among Indigenous Peoples Worldwide: A Systematic Review of Challenges and Opportunities.
2025cited by 0position: contributordoi
Faecal microbial transfer and complex carbohydrates mediate protection against COPD
Gut 2024cited by 58position: middledoi
The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.
2024cited by 44position: contributordoi
Faecal microbial transfer and complex carbohydrates mediate protection against COPD.
2024cited by 41position: contributordoi
Estimates of the eligible population for Australia’s targeted National Lung Cancer Screening Program, 2025–2030
Public Health Research & Practice 2024cited by 7position: middledoi
Lung cancer screening - Time for an update?
2024cited by 2position: contributordoi
Estimates of the eligible population for Australia’s targeted National Lung Cancer Screening Program, 2025-2030
2024cited by 0position: contributordoi
IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer
Journal of Thoracic Oncology 2023cited by 123position: middledoi
Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules
CHEST Journal 2023cited by 35position: middledoi
Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules
CHEST 2023cited by 34position: contributordoi
Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement.
2023cited by 6position: contributordoi
The tobacco endgame for the Asia Pacific.
2023cited by 5position: contributordoi
Vertebral CT attenuation outperforms standard clinical fracture risk prediction tools in detecting osteoporotic disease in lung cancer screening participants.
2023cited by 5position: contributordoi
Lung cancer: Removing toxic dust from our environment.
2023cited by 2position: contributordoi
Air pollution and lung cancer-A new era.
2023cited by 2position: contributordoi
Stage IV lung cancer: the relevance of tumour profile for the construction of prognostic groups.
2023cited by 0position: contributordoi
Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease
JAMA 2022cited by 79position: middledoi
Plasma Extracellular Vesicle miRNA Profiles Distinguish Chronic Obstructive Pulmonary Disease Exacerbations and Disease Severity.
2022cited by 11position: contributordoi
Lung cancer treatment patterns and factors relating to systemic therapy use in Australia.
2022cited by 8position: contributordoi
Lung cancer screening-Marching along ….
2022cited by 3position: contributordoi
More than meets the eye.
2022cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 21 papers (2021–2026)Ian A. Yang · The University of Queensland19 papers (2019–2026)Henry M. Marshall · Queensland Health9 papers (2022–2026)Karen Canfell · Sydney Local Health District7 papers (2017–2025)Nichole T. Tanner · Medical University of South Carolina5 papers (2020–2025)Gail Garvey · First Nations Health and Social Secretariat of Manitoba4 papers (2015–2025)Marianne F. Weber · The University of Sydney4 papers (2019–2024)Annette McWilliams · The University of Western Australia4 papers (2017–2025)Henry Marshall · University of Queensland4 papers (2013–2020)Marianne Weber · The University of Sydney4 papers (2017–2025)Patricia C. Valery · Australian National University3 papers (2015–2018)Renda Soylemez Wiener · Government of the United States of America3 papers (2020–2023)Hannah E O'Farrell · Queensland University of Technology3 papers (2021–2026)Suzanne K. Chambers · University of Southern Queensland3 papers (2015–2018)David Ball · Boston Children's Hospital3 papers (2015–2018)Shalini Vinod · UNSW Sydney3 papers (2015–2018)Michael K. Gould · Kaiser Permanente3 papers (2020–2023)Ella A. Kazerooni · Henry Ford Health System2 papers (2020–2020)Peter J. Mazzone · Istituto Zooprofilattico Sperimentale del Mezzogiorno2 papers (2020–2020)Renda Soylemez Wiener · Boston University2 papers (2020–2020)